Every month, a research paper reporting a new bioink or modification of an existing one is published. All these new options provide increasingly more specialized materials for specific applications. However,
Philadelphia, PA – Allevi Inc., a leader in the field of 3D bioprinting, announces that Taciana Pereira has been named as its Chief Scientific Officer. Taci has been at Allevi
ALLEVI 3D ANNOUNCES THE APPOINTMENT OF FRANK J. McCANEY Philadelphia, PA – Today the Board of Directors of Allevi 3D Inc., a leader in the field of bioprinting, announced that
Hadi Rastin together with his colleagues from the University of Adelaide in Australia created a new electroconductive bioink that can be combined with cells and easily extruded with excellent results.
Allevi Inc. and the Wistar Institute Collaborate on 3D Bioprinting Project to Advance COVID-19 Research
Allevi 3D bioprinted lung models will be used to study SARS-CoV-2 mechanisms of disease progression PHILADELPHIA — (June 25th, 2020) — The Wistar Institute, a biomedical research leader in cancer,
In their recent publication, Allevi authors Serkan Dikici, Fredrick Claeyssens, and Sheila MacNeil developed a very clever synthetic vascular network (SVN) by combining electro-spun layers with 3D bioprinted vascular channels.
Bioprinting always requires consideration of many different parameters: biomaterial mechanical and biological properties, printability, cell viability and many more. It requires finding a fine balance between all the factors and
“Shrinking printing” opens the possibility to improve your 3D bioprinting resolution with quick and simple post-processing. If your goal is to create small channels, a fine mesh, or similar micro-geometries
A bioprinted construct is only as good as the bioink used to create it. There are many biomaterial options available on the market, however, the need for more customized hydrogels
After 30 years of discoveries and over 10,000 citations, Corning® Matrigel® matrix has cemented its place as a trusted ECM in labs worldwide. Biologists, tissue engineers, and industry giants alike rely
We’ve always thought the Allevi 1 was a work of art, but now it’s official! We’re honored to be included in a major exhibition on display at the Philadelphia Museum
If stem cell therapies take off – we’re going to need a way to solve the stem cell supply problem – read on to learn more: The Promise We’ve all